In view of the pharmacological activity profile of Cerebrolysin the possibility of additive effects must be borne in mind during concomitant administration of antidepressants or MAO inhibitors. In such cases it is recommended that the dosage of the antidepressant be reduced.
Cerebrolysin should not be administered at the same time as balanced amino acid solutions in one infusion.